CH

Coherus BioSciences

- NASDAQ:CHRS
Last Updated 2024-04-19
  • Coherus BioSciences | A Biosimilar Therapeutics Developer

  • Locations

    • Redwood City CA

  • Total Funding (USD)

    327.5 million

  • Industries

    Software, Mobile Apps, Video Games, Real Estate, Internet

  • Acquisitions (1)

    • InteKrin (2014)

  • Security

    Type: ORD
    CUSIP: 19249H103
    ISIN: US19249H1032
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo